Who owns Spyre Therapeutics (SYRE)? Superinvestor holders
1 superinvestor of the 157 tracked here holds Spyre Therapeutics (SYRE) in their latest 13F filing, a position of $90.1M. Brandon Haley gives it the most weight: 0.21% of the reported portfolio. In their latest reported quarter, Brandon Haley opened a position.
Peter Kolchinsky, Julian and Felix Baker and Chuck Royce (founder) sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 1 of 157
- Biggest holder
- Brandon Haley, $90.1M
- Largest weight
- Brandon Haley, 0.21%of their portfolio
- Combined value
- $90.1M
- Bought last quarter
- 1
- Sold last quarter
- 3
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Brandon HaleyHolocene Advisors | 0.21% | $90.1M | 1.02M | New | +1.02M | Q2 2026 |
Sold out last quarter
- Peter Kolchinskywas $81.8M · Q2 2026
- Julian and Felix Bakerwas $50.4M · Q2 2026
- Chuck Royce (founder)was $4.6M · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 0 | — | — | 0 | 1 |
| Q2 2026 | 157 | 1 | 1.02M | $90.1M | 1 | 2 |
| Q1 2026 | 157 | 2 | 2.62M | $132.2M | 0 | 0 |
| Q4 2025 | 157 | 2 | 2.62M | $85.9M | 1 | 0 |
| Q3 2025 | 157 | 1 | 1M | $16.8M | 1 | 0 |
| Q2 2025 | 157 | 1 | 626.7K | $9.4M | 1 | 0 |
| Q1 2025 | 156 | 0 | — | — | 0 | 0 |
| Q4 2024 | 156 | 1 | 250K | $5.8M | 1 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Brandon Haley | · | 1.02M | — | — | — | — | — | — |
| Peter Kolchinsky | · | — | 1.62M | 1.62M | — | — | — | — |
| Julian and Felix Baker | · | — | 1M | 1M | 1M | 626.7K | — | — |
| George Soros | — | — | — | — | — | — | — | 250K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own SYRE?
In their latest 13F filings: Brandon Haley (0.21% of the portfolio, $90.1M).
Who bought SYRE last quarter?
Brandon Haley (new position). “Last quarter” is each investor's latest reported quarter.
Who sold SYRE last quarter?
Sold out entirely: Peter Kolchinsky (was $81.8M), Julian and Felix Baker (was $50.4M), Chuck Royce (founder) (was $4.6M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Spyre Therapeutics (SYRE)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/SYRE/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to SYRE by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.